Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3551-3560

  Braaten, Douglas ^a   Franke, Ettaly Kara ^a   Luban, Jeremy ^a  

^a The New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN A;

ARTICLE; DNA SYNTHESIS; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; GENE DISRUPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE FUSION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; TRANSCRIPTION INITIATION; VIRION; VIRUS ASSEMBLY; VIRUS INFECTION;

EID: 0029949799     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.3551-3560.1996     Document Type: Article

References (73)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Anderson, S., A. T. Bankier, B. G. Barrell, M. H. L. deBruijn, A. R. Coulson. H. Drouin, I. C. Eperon, D. P. Nierlich, B. A. Roe, S. Sanger, P. H. Schreier, A. J. H. Smith, R. Staden, and I. G. Young. 1981. Sequence and organization of the human mitochondrial genome. Nature (London) 290:457-465.
3. Baker, E. K., N. J. Colley, and C. S. Zuker. 1994. The cyclophilin homolog NinaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin. EMBO J. 13:4886-4895.
4. Bartz, S. R., E. Hohenwalter, M.-K. Hu, D. H. Rich, and M. Malkovsky. 1995. Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A. Proc. Natl. Acad. Sci. USA 92:5381-5385.
5. Bediniger, P., A. Moriarty, R. C. von Borstle, N. J. Donovan, K. S. Steimer, and D. R. Littman. 1988. Internalization of the human immunodeficiency virus does not require the cytoplasmic domain of CD4. Nature (London) 334:162-165.
6. Billich, A., F. Hammmchmid, P. Peichl, R. Wenger, G. Zenke, V. Quesniaux, and B. Rosenwirth. 1995. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1 : interference with HIV protein-cyclophilin A interactions. J. Virol. 69:2451-2461.
7. Bowerman, B., P. O. Brown, J. M. Bishop, and H. E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478.
8. CPZGAB but not group O HIV-1 or other primate immunodeficiency viruses. Submitted for publication.
9. 7b.Braaten, D., and J. Luban. Unpublished data.
10. Bryant, M., and L. Ratner. 1990. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA 87:523-527.
11. Bukrinsky, M. I., S. Haggerty, M. P. Dempsey, N. Sharova, A. Adzhubel, L. Spitz, P. Lewis, D. Goldfarb, M. Emerman, and M. Stevenson. 1943. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (London) 365:666-669.
12. Bukrinsky, M. I., N. Sharova, T. L. McDonald, T. Pushkarskaya, W. G. Tarpley, and M. Stevenson. 1993. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90:6125-6129.
13. Chattopadhyay, S. K., A. I. Oliff, D. L. Linemeyer, M. R. Lander, and D. R. Lowy. 1981. Genomes of murine leukemia viruses isolated from wild mice. J. Virol. 39:777-791.
14. Crawford, S., and S. P. Goff. 1984. Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection. J. Virol. 49:909-917.
15. Dimitrov, D. S., R. L. Willey, H. Sato, L.-J. Chang, R. Bluraenthal, and M. A. Martin. 1993. Quantitation of human immunodeficiency virus type I infection kinetics. J. Virol. 67:2182-2190.
16. Dorfman, T., F. Mammano, W. A. Haseltine, and H. G. Gottlinger. 1994. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1689-1696.
17. Farnet, C. M., and W. A. Haseltine. 1991. Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1910-1915.
18. Fischer, G., and F. X. Schmid. 1990. The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and transloeation in the cell. Biochemistry 29:2205-2212.
19. Franke, E. K., and J. Luban. Unpublished data.
20. Franke, E. K., H. E. H. Yuan, and J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature (London) 372:359-362.
21. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
22. Gelderblom, H. R., E. H. S. Hausmann, M. Ozel, G. Pauli, and M. A. Koch. 1987. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171-176.
23. Gething, M.-J., and J. Sambrook. 1992. Protein folding in the cell. Nature (London) 355:33-45.
24. Goff, S. P., P. Traktman, and D. Baltimore. 1981. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptasc. J. Virol. 38:239-248.
25. Göttlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
26. Hirt, B. 1967. Selective extraction of polyomavirus DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
27. Hsu, H. W., P. Schwartberg, and S. P. Goff. 1985. Point mutations in the p30 domain of the gag gene of Moloney leukemia virus. Virology 142:211-214.
28. Karpas, A., M. Lowdell, S. Jacobson, and F. Hill. 1992. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK506. Proc. Natl. Acad. Sci. USA 89:8351-8355.
29. Katoh, I., Y. Yoshinaka, A. Rein, M. Shibuya, T. Odaka, and S. Oroszlan. 1985. Murine leukemia virus maturation: protease region required for conversion from "immature" to "mature" core form and for virus infectivity. Virology 145:280-292.
30. Kim, S., R. Byrn, J. Groopman, and D. Baltimore. 1989. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 63:37118-3713.
31. Koletsky, A. J., M. W. Harding, and R. E. Handschumacher. 1986. Cyclophilin: distribution and variant properties in normal and neoplastic tissues. J. Immunol. 137:1054-1059.
32. Lavallee, C., X. J. Van, A. Ladha, H. Göttlinger, W. A. Haseltine, and E. A. Cohen. 1994. Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency type I viral particles. J. Immunol. 68:1926-1934.
33. Layne, S. P., M. J. Merges, M. Dembo, J. L. Spouge, S. R. Conley, J. P. Moore, J. L. Raina, H. Renz, H. R. Gelderblom, and P. L. Nara. 1992. Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus. Virology 189:695-714.
34. Levy, D. N., L. S. Fernandes, W. V. Williams, and D. B. Weiner. 1993. Induction of cell differentiation by human immunodeficiency virus I vpr. Cell 72:541-550.
35. Linial, M. L., and A. D. Miller. 1990. Retroviral RNA packaging: sequence requirements and implications. Curr. Top. Microbiol. Immunol. 157:125-152.
36. Lu, Y.-L., P. Spearman, and L. Ratner. 1993. Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67:6542-6550.
37. Luban, J., K. A. Bossolt, E. K. Franke, G. V. Kalpana, and S. P. Goff. 1993. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73:1067-1078.
38. Luban, J., and S. P. Goff. 1991. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein. J. Virol. 65:3203-3212.
39. Luban, J., C. Lee, and S. P. Goff. 1993. Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria. J. Virol. 67:3630-3634.
40. Maddon, P. J., J. S. McDougal, P. R. Clapham, A. G. Dalgleish, S. Jamal, R. A. Weiss, and R. Axel. 1988. HIV infection does not require endocytosis of its receptor. Cell 54:865-874.
41. Mammano, F., A. Ohagen, S. Hoglund, and H. G. Göttlinger. 1994. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J. Virol. 68:4927-1936.
42. Markowitz, D., S. Golf, and A. Bank. 1988. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167:400-406.
43. Matouschek, A., S. Rospert, K. Schmid, B. S. Click, and G. Schatz. 1995. Cyclophilin catalyzes protein folding in yeast mitochondria. Proc. Natl. Acad. Sci. USA 92:6319-6323.
44. Ondek, B., R. W. Hardy, E. K. Baker, M. A. Stamnes, B. H. Shieh, and C. S. Zuker. 1992. Genetic dissection of cyclophilin function. Saturation mutagenesis of the Drosophila cyclophilin homolog ninaA. J. Biol. Chem. 267:16460-16466.
45. Page, K. A., N. R. Landau, and D. R. Littman. 1990. Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J. Virol. 64:5270-5276.
46. gag and is incorporated into viruslike particles. J. Virol. 66:6304-6313.
47. Paxton, W., R. I. Connor, and N. R. Landau. 1993. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J. Virol. 67:7229-7237.
48. Piatak, M., M. S. Saag, L. C. Yang, S. J. Clark, J. C. Kappes, K.-C. Luk, B. H. Hahn, G. M. Shaw, and J. D. Lifson. 1993. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
49. Pryciak, P. M., and H. E. Varmus. 1992. Fr-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro. J. Virol. 66:5959-5966.
50. Reicin, A. S., S. Paik, R. D. Berkowitz, J. Luban, I. Lowy, and S. P. Goff. 1995. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J. Virol. 69:642-650.
51. Rein, A., M. McClure, N. Rice, R. Luftig, and A. Schultz. 1986. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. USA 83:7246-7250.
52. Rhee, S. S., and E. Hunter. 1987. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids. J. Virol. 61:1045-1053.
53. Rosenwirth, B., A. Billich, R. Datema, P. Donatsch, F. Hammerschmid, R. Harrison, P. Hiestand, H. Jaksche, P. Mayer, P. Peichl, V. Quesniaux, F. Schatz, H.-J. Schuurman, R. Traber, R. Wenger, B. Wolff, G. Zenke, and M. Zurini. 1994. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob. Agents Chemother. 38:1763-1772.
54. Rothman, J. E., and S. L. Schmid. 1986. Enzymatic recycling of clathrin from coated vesicles. Cell 46:5-9.
55. Russel, M., and P. Model. 1986. The role of thioredoxin in filamentous phage assembly. Construction, isolation, and characterization of mutant thioredoxins. J. Biol. Chem. 261:14997-15005.
56. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
57. Schreiber, S. L., and G. R. Crabtree. 1992. The mechanism of action of cyclosporin A and FK506. Immunol. Today 13:136-142.
58. Smith, A. J., N. Srinivasakumar, M.-L. Hammarskjöld, and D. Rekosh. 1993. Requirements for incorporation of Pr160 from human immunodeficiency virus type 1 into virus-like particles. J. Virol. 67:2266-2275.
59. Stamnes, M. A., S. L. Rutherford, and C. S. Zuker. 1992. Cyclophilins: a new family of proteins involved in intracellular folding. Trends Cell Biol. 2:272-276.
60. Stein, B. S., S. D. Gowda, J. D. Lifson, R. C. Penhallow, K. G. Bensch, and E. G. Engleman. 1987. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49:659-668.
61. Steinkasserer, A., R. Harrison, A. Billich, F. Hammerschmid, G. Werner, B. Wolff, P. Peichl, G. Palfi, W. Schnitzel, E. Mlynar, and B. Rosenwirth. 1995. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication. J. Virol. 69:814-824.
62. Stewart, L., G. Schatz, and V. M. Vogt. 1990. Properties of avian retrovirus particles defective in viral protease. J. Virol. 64:5076-5092.
63. Strambio-de-Castillia, C., and E. Hunter. 1992. Mutational analysis of the major homology region of Mason-Pfizer monkey virus by use of saturation mutagenesis. J. Virol. 66:7021-7032.
64. Sykes, K., M.-J. Gething, and J. Sambrook. 1993. Proline isomerases function during heal shock. Proc. Natl. Acad. Sci. USA 90:5853-5857.
65. Thali, M., A. A. Bukovsky, E. Kondo, B. Rostnwirth, C. T. Walsh, J. Sodroski, and H. G. Göltlinger. 1994. Specific association of cydoptiilin A with human immunodeficiency virus type 1 virions. Nature (London) 372:363-365.
66. Trono, D. 1995. HIV accessory proteins: leading roles for the supporting cast. Cell 82:189-192.
67. Wainberg, M., A. Dascal, N. Hlain, L. Fitz-Gibbon, F. Boulerice, K. Numazaki, and M. Trerablay. 1988. The effect of cyclosporine A on infection til susceptible cells by burmm immunodeficiency virus type 1. Blood 72:1904-1910.
68. Wang, C.-T., and E. Barklis. 1993. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol. 67:4264-4273.
69. Weiss, A., R. Wiskocil, and J. Stobo. 1984. The role of T3 surface molecules in the activation of human T cells: a two stimulus requirement for IL-2 production reflects events occurring at a pretranslational level. J. Immunol. 133:123-128.
70. Weiss, R., N. Teich, H. Varmus, and J. Coffin (ed.). 1184. RNA tumor viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
71. Wills, J. W., and R. C. Craven. 1991. Form, function, and use of retroviral Gag proteins. AIDS 5:639-654.
72. Yu, X., X. Yuan, Z. Matsuda, T.-H. Lee, and M. Essex. 1992. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66:4966-4971.
73. Zybarth, G., and C. Carter. 1995. Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag-Pol influence PR autoprocessing. J. Virol. 69:3878-3884.